Gosset NextStep Robotics General Information
The company’s flagship product, AMBLE, has been registered with the FDA and launched commercially in select clinics. Clinical results show that AMBLE provides safe and effective assistance for foot drop rehabilitation after stroke and other neurological injuries. The company has received significant NIH funding ($4.5M) to support clinical trials and commercialization efforts. Key findings include improved mobility, muscle strength, coordination, objective progress tracking via software analytics, and high patient satisfaction. A soft launch of the commercial product began in select clinics in early/mid–2024.
Contact Information
United States
Drug Pipeline
Key Partnerships
University of Maryland Baltimore/BioPark spinout, National Institutes of Health grant recipient, TEDCO investment partner
NextStep Robotics Funding
No funding data available